Pharmaceutical price regulation: national policies versus global interests
Increasing global regulation of drug prices and expenditures already affects the efficiency of pharmaceutical R&D and of health care delivery, with important implications for patient care now and in the future. The author examines the effect of existing foreign regulation - price controls, rate-...
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Buch |
| Sprache: | English |
| Veröffentlicht: |
Washington, D.C.
AEI Press
1997
|
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis |
| Zusammenfassung: | Increasing global regulation of drug prices and expenditures already affects the efficiency of pharmaceutical R&D and of health care delivery, with important implications for patient care now and in the future. The author examines the effect of existing foreign regulation - price controls, rate-of-return regulations, and industrial policies - on U.S. and other multinational producers of innovative drugs. She explores the growing threat to global revenues from the regulatory use of international price comparisons and the increasing threat from parallel trade. |
| Beschreibung: | VII, 107 S. graph. Darst. |
| ISBN: | 0844739820 0844739839 |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV011439149 | ||
| 003 | DE-604 | ||
| 005 | 19970909 | ||
| 007 | t | ||
| 008 | 970716s1997 d||| |||| 00||| eng d | ||
| 020 | |a 0844739820 |9 0-8447-3982-0 | ||
| 020 | |a 0844739839 |9 0-8447-3983-9 | ||
| 035 | |a (OCoLC)34477106 | ||
| 035 | |a (DE-599)BVBBV011439149 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-12 |a DE-739 |a DE-703 |a DE-M382 |a DE-83 | ||
| 050 | 0 | |a HD9666.4 | |
| 082 | 0 | |a 338.4/36151/0973 |2 20 | |
| 084 | |a QR 525 |0 (DE-625)142044: |2 rvk | ||
| 100 | 1 | |a Danzon, Patricia M. |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Pharmaceutical price regulation |b national policies versus global interests |c Patricia M. Danzon |
| 264 | 1 | |a Washington, D.C. |b AEI Press |c 1997 | |
| 300 | |a VII, 107 S. |b graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 520 | 3 | |a Increasing global regulation of drug prices and expenditures already affects the efficiency of pharmaceutical R&D and of health care delivery, with important implications for patient care now and in the future. The author examines the effect of existing foreign regulation - price controls, rate-of-return regulations, and industrial policies - on U.S. and other multinational producers of innovative drugs. She explores the growing threat to global revenues from the regulatory use of international price comparisons and the increasing threat from parallel trade. | |
| 650 | 7 | |a Drogues - Prix - États-Unis |2 ram | |
| 650 | 7 | |a Farmaceutische industrie |2 gtt | |
| 650 | 7 | |a Geneesmiddelen |2 gtt | |
| 650 | 7 | |a Industrie pharmacautique - Etats-Unis |2 ram | |
| 650 | 7 | |a Industrie pharmaceutique - Etats-Unis |2 ram | |
| 650 | 4 | |a Industrie pharmaceutique - États-Unis | |
| 650 | 4 | |a Médicaments - Politique gouvernementale - États-Unis | |
| 650 | 7 | |a Médicaments - Prix - Etats-Unis |2 ram | |
| 650 | 4 | |a Médicaments - Prix - États-Unis | |
| 650 | 7 | |a Politique pharmaceutique - États-Unis |2 ram | |
| 650 | 7 | |a Prijsbeleid |2 gtt | |
| 650 | 4 | |a Cost Control | |
| 650 | 4 | |a Drug Costs | |
| 650 | 4 | |a Drugs |x Prices |z United States | |
| 650 | 4 | |a Economics, Pharmaceutical | |
| 650 | 4 | |a Pharmaceutical industry |z United States | |
| 650 | 4 | |a Pharmaceutical policy |z United States | |
| 650 | 4 | |a Public Policy | |
| 650 | 0 | 7 | |a Arzneimittelmarkt |0 (DE-588)4003131-7 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Gesundheitspolitik |0 (DE-588)4113743-7 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Preisregelung |0 (DE-588)4175629-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneimittelpreis |0 (DE-588)4139908-0 |2 gnd |9 rswk-swf |
| 651 | 4 | |a USA | |
| 651 | 7 | |a USA |0 (DE-588)4078704-7 |2 gnd |9 rswk-swf | |
| 655 | 7 | |a Preisregulierung |2 gnd |9 rswk-swf | |
| 689 | 0 | 0 | |a USA |0 (DE-588)4078704-7 |D g |
| 689 | 0 | 1 | |a Arzneimittelpreis |0 (DE-588)4139908-0 |D s |
| 689 | 0 | 2 | |a Preisregulierung |A f |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a USA |0 (DE-588)4078704-7 |D g |
| 689 | 1 | 1 | |a Arzneimittelpreis |0 (DE-588)4139908-0 |D s |
| 689 | 1 | 2 | |a Preisregelung |0 (DE-588)4175629-0 |D s |
| 689 | 1 | |5 DE-604 | |
| 689 | 2 | 0 | |a USA |0 (DE-588)4078704-7 |D g |
| 689 | 2 | 1 | |a Arzneimittelmarkt |0 (DE-588)4003131-7 |D s |
| 689 | 2 | 2 | |a Gesundheitspolitik |0 (DE-588)4113743-7 |D s |
| 689 | 2 | |5 DE-604 | |
| 856 | 4 | 2 | |m GBV Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=007693312&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-007693312 | ||
Datensatz im Suchindex
| _version_ | 1804125955640262656 |
|---|---|
| adam_text | TO PHARMACEUTICAL PRICE REGULATION NATIONAL POLICIES VERSUS GLOBAL
INTERESTS PATRICIA M. DANZON THE AEI PRESS PUBLISHER FOR THE AMERICAN
ENTERPRISE INSTITUTE WASHINGTON, D.C. 1997 CONTENTS 1 INTRODUCTION THE
ECONOMICS OF PHARMACEUTICAL COSTS AND PRICING 5 THE COST STRUCTURE OF
INNOVATIVE PHARMACEUTICALS 5 THE ECONOMICS AND POLITICS OF DRUG PRICE
REGULATION 9 OPTIMAL PRICING TO SHARE JOINT COSTS 11 SUMMARY 13
REGULATION OF PHARMACEUTICAL PRICES AND EXPENDITURES 15 THE OBJECTIVES
OF PRICE REGULATION 15 FORMS OF PRICE REGULATION 16 EFFECTS OF
REGULATION ON DRUG PRICES AND EXPENDITURES , 30 PRICE INDEXES 30 GROWTH
IN DRUG EXPENDITURES 37 VOLUME PER CAPITA 39 MIX OF DRUGS 41 CONCLUSION
45 EFFECTS OF REGULATION ON INNOVATION 46 INNOVATION STRATEGIES OF THE
PHARMACEUTICAL FIRM 47 REVENUE EFFECTS OF REGULATION 49 EFFECTS OF
REGULATION ON THE COST OF CAPITAL 56 EFFECTS ON DOMESTIC AND FOREIGN
FIRMS 56 CONTENTS EMPIRICAL EVIDENCE 58 CONCLUSIONS 63 6 7 EFFECTS OF
REGULATION ON PRODUCTIVITY 65 INCENTIVE EFFECTS OF BIASED REGULATION 66
DATA AND EMPIRICAL METHODS 68 EMPIRICAL RESULTS 69 CONCLUSIONS 80
CROSS-NATIONAL MULTIPLIER EFFECTS OF REGULATION 84 WELFARE IMPLICATIONS
OF PARALLEL TRADE 85 POLICY OPTIONS 89 Q CONCLUSIONS REFERENCES INDEX
ABOUT THE AUTHOR 92 99 103 TABLES 2-1 THE COST STRUCTURE OF
PHARMACEUTICALS: DISCOUNTED PRESENT VALUE AT LAUNCH 6 4-1 PRICE INDEXES
IN SELECTED COUNTRIES, RELATIVE TO THE UNITED STATES, 1992 31 4-2 GROWTH
IN REAL PER CAPITA EXPENDITURES ON PHARMACEUTICALS IN SELECTED
COUNTRIES, 1970-1990 38 4-3 DRUG VOLUME PER CAPITA IN SELECTED
COUNTRIES, 1981-1990 40 4-4 MARKETS FOR SINGLE-MOLECULE CARDIOVASCULAR
PRODUCTS (OUTPATIENT PHARMACY) IN SELECTED COUNTRIES, 1992 43 5-1 R&D
SHARE OF SALES IN SELECTED COUNTRIES, RELATIVE TO THE UNITED STATES,
1981-1991 61 6-1 GROWTH IN NUMBER OF EMPLOYEES IN SELECTED COUNTRIES,
1975-1990 70 6-2 VALUE ADDED PER EMPLOYEE IN SELECTED COUNTRIES,
RELATIVE TO THE UNITED STATES, 1970-1990 72 VI CONTENTS 6-3 VALUE ADDED
PER EMPLOYEE IN SELECTED COUNTRIES, RELATIVE TO THE UNITED STATES,
1981-1990 73 6-4 GROWTH IN GROSS FIXED CAPITAL FORMATION IN SELECTED
COUNTRIES, 1975-1990 74 6-5 GROWTH IN GROSS FIXED CAPITAL FORMATION PER
EMPLOYEE IN SELECTED COUNTRIES, 1975-1990 75 6-6 LABOR COMPENSATION PER
EMPLOYEE IN SELECTED COUNTRIES, RELATIVE TO THE UNITED STATES, 1970-1990
77 6-7 HYPOTHETICAL EX POST RETURN TO PHYSICAL CAPITAL, ASSUMING NO
INTANGIBLE CAPITAL, 1976-1990 79 FIGURES 4-1 PRICE PER STANDARD UNIT IN
SELECTED COUNTRIES, RELATIVE TO THE UNITED STATES 35 5-1 GROWTH IN REAL
R&D EXPENDITURES IN SELECTED COUNTRIES, 1981-1991 59 VLL
|
| any_adam_object | 1 |
| author | Danzon, Patricia M. |
| author_facet | Danzon, Patricia M. |
| author_role | aut |
| author_sort | Danzon, Patricia M. |
| author_variant | p m d pm pmd |
| building | Verbundindex |
| bvnumber | BV011439149 |
| callnumber-first | H - Social Science |
| callnumber-label | HD9666 |
| callnumber-raw | HD9666.4 |
| callnumber-search | HD9666.4 |
| callnumber-sort | HD 49666.4 |
| callnumber-subject | HD - Industries, Land Use, Labor |
| classification_rvk | QR 525 |
| ctrlnum | (OCoLC)34477106 (DE-599)BVBBV011439149 |
| dewey-full | 338.4/36151/0973 |
| dewey-hundreds | 300 - Social sciences |
| dewey-ones | 338 - Production |
| dewey-raw | 338.4/36151/0973 |
| dewey-search | 338.4/36151/0973 |
| dewey-sort | 3338.4 536151 3973 |
| dewey-tens | 330 - Economics |
| discipline | Wirtschaftswissenschaften |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03516nam a2200769 c 4500</leader><controlfield tag="001">BV011439149</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">19970909 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">970716s1997 d||| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0844739820</subfield><subfield code="9">0-8447-3982-0</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0844739839</subfield><subfield code="9">0-8447-3983-9</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)34477106</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV011439149</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-739</subfield><subfield code="a">DE-703</subfield><subfield code="a">DE-M382</subfield><subfield code="a">DE-83</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">HD9666.4</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">338.4/36151/0973</subfield><subfield code="2">20</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">QR 525</subfield><subfield code="0">(DE-625)142044:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Danzon, Patricia M.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Pharmaceutical price regulation</subfield><subfield code="b">national policies versus global interests</subfield><subfield code="c">Patricia M. Danzon</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Washington, D.C.</subfield><subfield code="b">AEI Press</subfield><subfield code="c">1997</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">VII, 107 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1="3" ind2=" "><subfield code="a">Increasing global regulation of drug prices and expenditures already affects the efficiency of pharmaceutical R&D and of health care delivery, with important implications for patient care now and in the future. The author examines the effect of existing foreign regulation - price controls, rate-of-return regulations, and industrial policies - on U.S. and other multinational producers of innovative drugs. She explores the growing threat to global revenues from the regulatory use of international price comparisons and the increasing threat from parallel trade.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Drogues - Prix - États-Unis</subfield><subfield code="2">ram</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Farmaceutische industrie</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Geneesmiddelen</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Industrie pharmacautique - Etats-Unis</subfield><subfield code="2">ram</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Industrie pharmaceutique - Etats-Unis</subfield><subfield code="2">ram</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Industrie pharmaceutique - États-Unis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Médicaments - Politique gouvernementale - États-Unis</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Médicaments - Prix - Etats-Unis</subfield><subfield code="2">ram</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Médicaments - Prix - États-Unis</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Politique pharmaceutique - États-Unis</subfield><subfield code="2">ram</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Prijsbeleid</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cost Control</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Costs</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="x">Prices</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Economics, Pharmaceutical</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical industry</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical policy</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Public Policy</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelmarkt</subfield><subfield code="0">(DE-588)4003131-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Gesundheitspolitik</subfield><subfield code="0">(DE-588)4113743-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Preisregelung</subfield><subfield code="0">(DE-588)4175629-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelpreis</subfield><subfield code="0">(DE-588)4139908-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="651" ind1=" " ind2="4"><subfield code="a">USA</subfield></datafield><datafield tag="651" ind1=" " ind2="7"><subfield code="a">USA</subfield><subfield code="0">(DE-588)4078704-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="a">Preisregulierung</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">USA</subfield><subfield code="0">(DE-588)4078704-7</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Arzneimittelpreis</subfield><subfield code="0">(DE-588)4139908-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Preisregulierung</subfield><subfield code="A">f</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">USA</subfield><subfield code="0">(DE-588)4078704-7</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Arzneimittelpreis</subfield><subfield code="0">(DE-588)4139908-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="2"><subfield code="a">Preisregelung</subfield><subfield code="0">(DE-588)4175629-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="2" ind2="0"><subfield code="a">USA</subfield><subfield code="0">(DE-588)4078704-7</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="2" ind2="1"><subfield code="a">Arzneimittelmarkt</subfield><subfield code="0">(DE-588)4003131-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="2"><subfield code="a">Gesundheitspolitik</subfield><subfield code="0">(DE-588)4113743-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">GBV Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=007693312&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-007693312</subfield></datafield></record></collection> |
| genre | Preisregulierung gnd |
| genre_facet | Preisregulierung |
| geographic | USA USA (DE-588)4078704-7 gnd |
| geographic_facet | USA |
| id | DE-604.BV011439149 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T18:09:47Z |
| institution | BVB |
| isbn | 0844739820 0844739839 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-007693312 |
| oclc_num | 34477106 |
| open_access_boolean | |
| owner | DE-12 DE-739 DE-703 DE-M382 DE-83 |
| owner_facet | DE-12 DE-739 DE-703 DE-M382 DE-83 |
| physical | VII, 107 S. graph. Darst. |
| publishDate | 1997 |
| publishDateSearch | 1997 |
| publishDateSort | 1997 |
| publisher | AEI Press |
| record_format | marc |
| spelling | Danzon, Patricia M. Verfasser aut Pharmaceutical price regulation national policies versus global interests Patricia M. Danzon Washington, D.C. AEI Press 1997 VII, 107 S. graph. Darst. txt rdacontent n rdamedia nc rdacarrier Increasing global regulation of drug prices and expenditures already affects the efficiency of pharmaceutical R&D and of health care delivery, with important implications for patient care now and in the future. The author examines the effect of existing foreign regulation - price controls, rate-of-return regulations, and industrial policies - on U.S. and other multinational producers of innovative drugs. She explores the growing threat to global revenues from the regulatory use of international price comparisons and the increasing threat from parallel trade. Drogues - Prix - États-Unis ram Farmaceutische industrie gtt Geneesmiddelen gtt Industrie pharmacautique - Etats-Unis ram Industrie pharmaceutique - Etats-Unis ram Industrie pharmaceutique - États-Unis Médicaments - Politique gouvernementale - États-Unis Médicaments - Prix - Etats-Unis ram Médicaments - Prix - États-Unis Politique pharmaceutique - États-Unis ram Prijsbeleid gtt Cost Control Drug Costs Drugs Prices United States Economics, Pharmaceutical Pharmaceutical industry United States Pharmaceutical policy United States Public Policy Arzneimittelmarkt (DE-588)4003131-7 gnd rswk-swf Gesundheitspolitik (DE-588)4113743-7 gnd rswk-swf Preisregelung (DE-588)4175629-0 gnd rswk-swf Arzneimittelpreis (DE-588)4139908-0 gnd rswk-swf USA USA (DE-588)4078704-7 gnd rswk-swf Preisregulierung gnd rswk-swf USA (DE-588)4078704-7 g Arzneimittelpreis (DE-588)4139908-0 s Preisregulierung f DE-604 Preisregelung (DE-588)4175629-0 s Arzneimittelmarkt (DE-588)4003131-7 s Gesundheitspolitik (DE-588)4113743-7 s GBV Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=007693312&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Danzon, Patricia M. Pharmaceutical price regulation national policies versus global interests Drogues - Prix - États-Unis ram Farmaceutische industrie gtt Geneesmiddelen gtt Industrie pharmacautique - Etats-Unis ram Industrie pharmaceutique - Etats-Unis ram Industrie pharmaceutique - États-Unis Médicaments - Politique gouvernementale - États-Unis Médicaments - Prix - Etats-Unis ram Médicaments - Prix - États-Unis Politique pharmaceutique - États-Unis ram Prijsbeleid gtt Cost Control Drug Costs Drugs Prices United States Economics, Pharmaceutical Pharmaceutical industry United States Pharmaceutical policy United States Public Policy Arzneimittelmarkt (DE-588)4003131-7 gnd Gesundheitspolitik (DE-588)4113743-7 gnd Preisregelung (DE-588)4175629-0 gnd Arzneimittelpreis (DE-588)4139908-0 gnd |
| subject_GND | (DE-588)4003131-7 (DE-588)4113743-7 (DE-588)4175629-0 (DE-588)4139908-0 (DE-588)4078704-7 |
| title | Pharmaceutical price regulation national policies versus global interests |
| title_auth | Pharmaceutical price regulation national policies versus global interests |
| title_exact_search | Pharmaceutical price regulation national policies versus global interests |
| title_full | Pharmaceutical price regulation national policies versus global interests Patricia M. Danzon |
| title_fullStr | Pharmaceutical price regulation national policies versus global interests Patricia M. Danzon |
| title_full_unstemmed | Pharmaceutical price regulation national policies versus global interests Patricia M. Danzon |
| title_short | Pharmaceutical price regulation |
| title_sort | pharmaceutical price regulation national policies versus global interests |
| title_sub | national policies versus global interests |
| topic | Drogues - Prix - États-Unis ram Farmaceutische industrie gtt Geneesmiddelen gtt Industrie pharmacautique - Etats-Unis ram Industrie pharmaceutique - Etats-Unis ram Industrie pharmaceutique - États-Unis Médicaments - Politique gouvernementale - États-Unis Médicaments - Prix - Etats-Unis ram Médicaments - Prix - États-Unis Politique pharmaceutique - États-Unis ram Prijsbeleid gtt Cost Control Drug Costs Drugs Prices United States Economics, Pharmaceutical Pharmaceutical industry United States Pharmaceutical policy United States Public Policy Arzneimittelmarkt (DE-588)4003131-7 gnd Gesundheitspolitik (DE-588)4113743-7 gnd Preisregelung (DE-588)4175629-0 gnd Arzneimittelpreis (DE-588)4139908-0 gnd |
| topic_facet | Drogues - Prix - États-Unis Farmaceutische industrie Geneesmiddelen Industrie pharmacautique - Etats-Unis Industrie pharmaceutique - Etats-Unis Industrie pharmaceutique - États-Unis Médicaments - Politique gouvernementale - États-Unis Médicaments - Prix - Etats-Unis Médicaments - Prix - États-Unis Politique pharmaceutique - États-Unis Prijsbeleid Cost Control Drug Costs Drugs Prices United States Economics, Pharmaceutical Pharmaceutical industry United States Pharmaceutical policy United States Public Policy Arzneimittelmarkt Gesundheitspolitik Preisregelung Arzneimittelpreis USA Preisregulierung |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=007693312&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| work_keys_str_mv | AT danzonpatriciam pharmaceuticalpriceregulationnationalpoliciesversusglobalinterests |